Soken Chemical & Engineering Co., Ltd.

TSE:4972.T

3200 (JPY) • At close November 5, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) JPY.

20232022202120202019201820172016201520142013201220112010200920082007
Revenue 41,318.28638,129.97638,638.05731,493.97628,699.731,295.94530,050.86126,139.23426,019.8328,772.20327,561.04326,434.28524,573.50724,458.28323,782.14823,983.0829,823.12
Cost of Revenue 28,774.01727,952.16928,376.69520,905.99919,604.66922,214.96120,181.31517,014.67617,697.74520,103.88918,992.94518,165.06517,594.04716,812.19316,161.04818,287.24320,298.441
Gross Profit 12,544.26910,177.80710,261.36210,587.9779,095.0319,080.9849,869.5469,124.5588,322.0858,668.3148,568.0988,269.226,979.467,646.097,621.15,695.8379,524.679
Gross Profit Ratio 0.3040.2670.2660.3360.3170.290.3280.3490.320.3010.3110.3130.2840.3130.320.2370.319
Reseach & Development Expenses 1,335.9741,4041,4551,4211,4681,5221,599.0541,690.3781,953.352,1151,8371,76000000
General & Administrative Expenses 7,485.3798,143.4918,032.1727,190.0267,060.3986,967.0097,218.5216,837.3017,077.9137,238.3127,014.9666,636.5900000
Selling & Marketing Expenses 1,2301,2311,2089378136,967.0097,218.52167361968759960500000
SG&A 8,715.3798,143.4918,032.1727,190.0267,060.3986,967.0097,218.5216,837.3017,077.9137,238.3127,014.9666,636.5900000
Other Expenses 13.59745.374113.88184.03764.14987.628122.04568.67184.82870.90773.31527.62641.34514.35783.46313.356-57.31
Operating Expenses 8,715.3798,143.4918,032.1727,190.0267,110.9887,012.3327,281.3866,886.8787,103.6897,278.6237,014.9666,636.595,927.0335,939.2775,771.3965,337.6395,755.683
Operating Income 3,828.892,034.3162,229.1893,397.952,034.6322,113.9742,651.0242,287.2561,244.171,430.0011,553.1321,632.6281,052.4271,706.8121,849.704358.1973,768.995
Operating Income Ratio 0.0930.0530.0580.1080.0710.0680.0880.0880.0480.050.0560.0620.0430.070.0780.0150.126
Total Other Income Expenses Net -28.964-35556417-171-1932.8-321.346-223.49317.388-45.663-79.423-199.224-154.2847.675-274.83-282.395
Income Before Tax 3,799.9262,000.5022,773.893,715.3151,864.2511,922.2132,590.961,916.333994.9021,407.0781,507.4691,553.206853.2031,552.5291,857.37983.3683,486.601
Income Before Tax Ratio 0.0920.0520.0720.1180.0650.0610.0860.0730.0380.0490.0550.0590.0350.0630.0780.0030.117
Income Tax Expense 1,170.627563.702733.187990.502228.369459.297626.391539.264345.078428.467495.641520.473365.16427.738554.685118.3651,133.734
Net Income 2,629.2981,436.7992,040.7032,724.8131,635.8821,462.9151,964.5681,342.933529.838765.724913.989967.753401.6191,001.1791,174.327-104.5082,248.768
Net Income Ratio 0.0640.0380.0530.0870.0570.0470.0650.0510.020.0270.0330.0370.0160.0410.049-0.0040.075
EPS 317.69173.93247.51331.12198.38176.55237.09162.0763.9492.41110.3116.7948.47120.82141.72-12.61271.38
EPS Diluted 317.69173.93247.51331.12198.38176.55237.09162.0763.9492.41110.3116.7948.47120.82141.72-12.61271.38
EBITDA 6,067.5164,078.5364,715.1675,575.5443,295.2383,462.0074,093.9223,409.6562,867.7283,427.5473,441.7123,371.5072,714.4143,433.4563,934.1662,633.6885,260.794
EBITDA Ratio 0.1470.1070.1220.1770.1150.1110.1360.130.110.1190.1250.1280.110.140.1650.110.176